CDMO & Manufacturing

Bramble Energy is a UK hydrogen technology company developing printed-circuit fuel cells, electrolysers, and sensors. Founded in 2016 at Imperial College London and UCL, it operates from Crawley, England with a 34,000 sq ft manufacturing facility capable of producing 2,000 fuel cell stacks annually.

BÜCHI Labortechnik AG is a Switzerland‑based global supplier of laboratory and in‑process equipment for evaporation, spray drying, chromatography, extraction, distillation, digestion and NIR analysis. Its Rotavapor systems, spray dryers, freeze dryers and chromatography platforms are widely used in pharma and chemical R&D and QC, supported by extensive application guides, training and digital process‑control tools.

CDMO Pharma Services, part of LGM Pharma, is a full-service CDMO providing integrated drug product development, analytical services, and cGMP manufacturing from concept through commercialization. With strengths in formulation development and solid oral dosage manufacturing, it supports pharmaceutical and biotech partners across clinical and commercial stages while leveraging LGM’s API expertise.

BIOVECTRA is a North American CDMO specializing in biologics, small molecules, bioreagents and HPAPIs, with strong microbial fermentation and complex chemistry capabilities. From its Canadian base, it provides clinical-to-commercial development and GMP manufacturing of APIs, intermediates, recombinant proteins, plasmid DNA and antibody fragments, plus project support and educational resources for pharma and biotech partners.

CTC Analytics AG is a private Swiss laboratory automation company in Zwingen that designs and manufactures high-end laboratory robots and chromatography front-end automation systems. Working through integrated, agile teams across design, production, lab, testing and service, it emphasizes quality, safety, trust-based collaboration and long-term partnerships with life-science customers.

Calidi Biotherapeutics is a San Diego–based, clinical-stage biotech company developing targeted stem cell and viral immunotherapies for solid tumors and metastatic disease. Its proprietary Redtail platform enables systemic delivery of engineered oncolytic viruses, with lead candidate CLD-401 in IND-enabling studies for non-small cell lung and head and neck cancers.

CARB-X is a Boston University–led global non-profit accelerator focused on early-stage antibacterial R&D, funding new antibiotics, preventatives and rapid diagnostics against drug‑resistant bacteria. It provides non‑dilutive funding plus scientific, regulatory and business support to advance innovative products from basic research toward first‑in‑human studies, with a portfolio described as the world’s most diverse early antibacterial pipeline.

Autolomous is a UK‑based biotech SaaS company providing autoloMATE®, an end‑to‑end digital manufacturing and orchestration platform for cell, gene and advanced therapy manufacturing. It integrates siloed process data, enhances traceability and supports compliant scale‑up for academic labs, hospital GMP units, CDMOs and biopharma manufacturers across development, clinical trials and commercialisation.

Made Scientific is a Princeton, New Jersey–based cell therapy CDMO providing end-to-end development, GMP manufacturing, aseptic fill-finish, QC release, and workforce training for autologous and allogeneic therapies. Operating a 60,000 ft², FDA/EU Annex 1–aligned facility with ISO 7 cleanrooms and commercial expansion space, they support T cell, NK, MSC, iPSC, HSC, TIL, and exosome programs from pre-clinical through commercial supply.

LenioBio is a biotech company offering ALiCE®, a plant-based, eukaryotic cell-free protein expression platform and services for rapid, scalable production of complex proteins. The system supports full-length membrane proteins, post-translational modifications, and integration into automated workflows, serving pharma, biotech, CRO/CDMO, AI protein design, and vaccine and CGT developers. Buyers can engage via ALiCE® kits in their labs or through LenioBio’s protein expression services.

Celonic is a Swiss-based pure-play biologics CDMO providing end-to-end drug substance development and GMP manufacturing for monoclonal antibodies, bispecifics and complex biologics. With a development and innovation center in Basel and GMP facilities in Heidelberg, it leverages next-generation bioprocessing technologies such as process intensification and full perfusion, and collaborates with partners for fill-finish and integrated ADC platforms.

ChemAI is a UK-based private digital chemistry company using AI, proprietary reaction data and automation control to power route prediction, reaction optimisation and autonomous, closed-loop development and manufacturing. Working with global chemical, pharmaceutical and materials leaders, it industrialises AI in chemistry to improve process efficiency, yields and data quality across R&D and manufacturing.

Cleanroom Microbiology Solutions (AnalytiChem UK, formerly Cherwell) provides prepared microbiological media, air samplers, EM consumables and calibration services for pharmaceutical and cleanroom environments. Its Redipor® ISO 9001-certified facility delivers standard and bespoke solutions for EU GMP Annex 1-compliant environmental monitoring and process validation across pharma manufacturing, radiopharmacy and NHS hospital pharmacies.

Codexis is a specialist RNA manufacturer and enzyme engineering partner offering ECO Synthesis® and CodeEvolver® platforms for greener, scalable therapeutic manufacturing. The company provides RNA manufacturing, pharma biocatalysis and molecular biology enzyme solutions, along with RNA ligation and enzyme evolution services, to help pharma and biotech teams improve yield, quality and sustainability from development through scale‑up.

Creative Peptides is a New York–based peptide CDMO and supplier providing custom peptide synthesis, modification, conjugation, labeling, analysis, and GMP manufacturing. It offers bioactive peptide APIs and research-grade catalog products to support drug discovery, clinical development, and cosmetic innovation under strict cGMP quality systems.

Helus Pharma (Cybin Inc. d/b/a Helus Pharma) is a clinical-stage neuropsychiatry company developing next-generation serotonergic agonist therapies and proprietary delivery systems for mental health disorders. With two lead programs, a broad patent portfolio, and experienced neuropsychiatry and regulatory leadership, Helus focuses on durable, clinically practical treatments for conditions such as major depressive disorder and generalized anxiety disorder.

Cytiva is a global life sciences company providing end-to-end technologies, consumables, and services that support biopharma from discovery through commercial manufacturing. As part of Danaher, it offers leading brands such as ÄKTA, Amersham, HyClone, MabSelect, and Whatman, serving pharma, biotech, CDMOs, and academia with integrated bioprocessing and analytical solutions.

DEBRA Research is the global, non-profit research arm of DEBRA Austria dedicated to translational research and clinical development of therapies for Epidermolysis Bullosa (EB). It funds and co-develops EB treatment programs, invests in biotech partners, and builds specialized clinical trial infrastructure to move promising EB therapies from lab to patients.

Protheragen’s Drug Ingredients and Chemicals division is an ISO 9001:2015–certified global supplier of APIs, excipients, intermediates, specialty chemicals, biomaterials and veterinary products, backed by extensive analytical and formulation capabilities. It offers API synthesis and contract manufacturing, impurity and stability testing, cosmetics safety analysis, and advanced novel drug delivery and nanoparticle/LNP solutions to support pharma, biotech and cosmetics R&D and procurement.

EKF Diagnostics is an AIM‑listed global diagnostics and biotechnology company headquartered near Cardiff, UK, with manufacturing in the USA and Germany. It offers point‑of‑care analyzers, central laboratory tests and media, and life sciences reagents and enzymes for healthcare, research and industrial applications across hematology, diabetes, connectivity, women’s health, sports, veterinary and bioprocessing.

Elemental Machines is a private LabOps connectivity and life sciences IoT company based in Cambridge, MA that unifies equipment, environmental, and workflow data into one platform. Its integrated hardware, software, and data science solutions enable continuous monitoring, contextual alerts, utilization analytics, and 21 CFR Part 11–compliant reporting for biopharma, R&D, manufacturing, academic, and government labs.

Elixirgen Therapeutics is a Baltimore-based clinical-stage biotech developing gene and RNA therapies for rare and aging-associated diseases using its ZSCAN4 telomere-elongation and Bobcat® mRNA platforms. Lead programs include EXG-34217, an autologous ZSCAN4-modified CD34+ cell therapy for Telomere Biology Disorders in Phase I/II trials with FDA Orphan, Rare Pediatric Disease, and RMAT designations, and EXG-7001, a Bobcat® mRNA candidate encoding full-length dystrophin for Duchenne muscular dystrophy in pre

Publicis Sapient is a global enterprise AI and digital transformation company that builds platforms like Bodhi, Slingshot and Sustain to modernize systems, orchestrate AI agents and automate IT operations. With deep industry context in health and other sectors, it helps large organizations move AI from pilots to secure production with faster delivery, cost savings and high accuracy.

Enzymit is an Israel-based synthetic biology company developing a proprietary computational enzyme design platform and cell-free bioproduction processes for novel biomolecular components and biochemicals. Its technology targets applications in biochemicals, food and beverages, personal care, and health and nutrition, delivering cheaper, efficient and sustainable enzyme-only manufacturing solutions.